Emergent BioSolutions Inc.EBSNYSE
Loading
Year-over-year net income growth rate
Percentile
P13
Within normal range
vs 5Y Ago
-0.6x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -206.64% |
| Q3 2025 | 526.67% |
| Q2 2025 | -117.65% |
| Q1 2025 | 317.25% |
| Q4 2024 | -127.26% |
| Q3 2024 | 140.55% |
| Q2 2024 | -3245.56% |
| Q1 2024 | 118.18% |
| Q4 2023 | 81.21% |
| Q3 2023 | -0.77% |
| Q2 2023 | -40.39% |
| Q1 2023 | -177.91% |
| Q4 2022 | 23.08% |
| Q3 2022 | -61.90% |
| Q2 2022 | -1354.05% |
| Q1 2022 | -101.95% |
| Q4 2021 | 678.90% |
| Q3 2021 | -810.87% |
| Q2 2021 | -93.40% |
| Q1 2021 | -62.41% |
| Q4 2020 | 369.37% |
| Q3 2020 | -57.39% |
| Q2 2020 | 841.60% |
| Q1 2020 | -126.65% |
| Q4 2019 | 8.56% |
| Q3 2019 | 554.74% |
| Q2 2019 | 63.46% |
| Q1 2019 | -642.86% |
| Q4 2018 | -116.75% |
| Q3 2018 | -58.28% |
| Q2 2018 | 1122.45% |
| Q1 2018 | -114.43% |
| Q4 2017 | 1.18% |
| Q3 2017 | 626.84% |
| Q2 2017 | -55.98% |
| Q1 2017 | -71.96% |
| Q4 2016 | 75.22% |
| Q3 2016 | 294.94% |
| Q2 2016 | -374.29% |
| Q1 2016 | -88.03% |